Zachary M Goldstein, MD
Dermatology · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 2 carriers
- Offices
- 6
Offices
6 locations · USC Care Medical Group Inc · 1,378 clinicians in this group
Hospitals listed: Keck Hospital of USC · USC Kenneth Norris Jr Cancer Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Goldstein’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A149661 · Current
Licensed to practise in California · since 2017 · expires 2027-06-30 · David Geffen School of Medicine at UCLA.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Keck Hospital of USCLos Angeles, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of University of Southern California, which runs 4 hospitalsHome of USC Norris Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 82% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.79 (0.6 to 0.97), Jul 2022 – Jun 2024Better than the national rate — Postoperative respiratory failure rate: 5.33 (2.15 to 8.51) · 2,872 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative sepsis rate: 2.25 (0.38 to 4.13) · 2,875 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.153, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.565, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.644, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.143, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.287, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.6 to 1) · 992 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Keck Hospital of USC
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.6 to 0.97) | Better | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.33 (2.15 to 8.51) · 2,872 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 2.25 (0.38 to 4.13) · 2,875 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.153 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.565 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.644 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.143 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.287 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1) · 992 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.47 to 1.79) · 3,513 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 178.09 (145.37 to 210.81) · 267 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.7 · 134 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.9 · 61 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 2,086 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0.03 to 0.39) · 6,677 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.12 to 0.48) · 7,784 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.38 (2.05 to 4.71) · 4,593 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.02 (0.97 to 3.08) · 2,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.52 (0.5 to 2.55) · 3,742 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.61 (1.35 to 3.87) · 1,628 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.17 to 1.02) · 5,896 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.9 · 128 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0.928 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 112 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.8 · 139 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 11.5 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 24.7 · 167 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -34.3 · 42 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.2 (2.8 to 6.3) · 103 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (7.8 to 14.3) · 103 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.3 · 140 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 43 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.9 to 14.5) · 1,774 cases | No different | Jan 2022 – Dec 2024 |
What patients said (744 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 80% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$47,572
Medicare paid this office $47,572 for 643 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Pathology examination of tissue using a microscope, intermediate complexity | 599 | $30,612 | $29 |
| Special stained specimen slides to examine tissue, initial procedure | 175 | $7,075 | $28 |
| Special stained specimen slides to examine tissue, each additional procedure | 94 | $4,494 | $23 |
| Special stained specimen slides to identify organisms including interpretation and report | 40 | $1,099 | $21 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 11 | $752 | $31 |
See all 6 services
| Pathology examination of tissue using a microscope, intermediate complexity | 599 | $30,612 | $29 |
| Special stained specimen slides to examine tissue, initial procedure | 175 | $7,075 | $28 |
| Special stained specimen slides to examine tissue, each additional procedure | 94 | $4,494 | $23 |
| Special stained specimen slides to identify organisms including interpretation and report | 40 | $1,099 | $21 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 11 | $752 | $31 |
| Pathology examination of tissue using a microscope, moderately low complexity | 41 | $408 | $9 |
Procedures Medicare counted
| Removal of skin lesions | 18 | More than 64% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 18 | More than 62% of doctors who do this |
Who their Medicare patients are
643 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 12% · Women 45% · Also on Medicaid 20% · Health risk score 1.40. Sicker patients than 9 in 10 peers; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 72% · Coronary heart disease 30% · Diabetes 28% · Chronic kidney disease 25% · Cancer 21% · Atrial fibrillation 18% · Depression 15% · Heart failure 14% · COPD 11% · Stroke 7% · Dementia 6%.
The office billed $269,734, Medicare allowed $61,133 and paid $47,572; for 1,687 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 643 | 1,687 | 75 | 1.40 | $269,734 | $47,572 |
| 2023 | 2,259 | 3,964 | 77 | 1.12 | $699,491 | $271,089 |
| 2022 | 5,312 | 9,990 | 77 | 1.02 | $1,773,860 | $727,339 |
| 2021 | 3,097 | 6,176 | 77 | 1.02 | $956,586 | $389,333 |
| 2020 | 367 | 1,146 | 76 | 1.03 | $125,403 | $46,031 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Pathology examination of tissue using a microscope, intermediate complexity | 1,876 | $182,484 | $69 |
| Special stained specimen slides to examine tissue, initial procedure | 409 | $42,984 | $101 |
| Special stained specimen slides to examine tissue, each additional procedure | 96 | $12,392 | $88 |
| Pathology examination of tissue using a microscope, moderately low complexity | 266 | $11,701 | $42 |
| Special stained specimen slides to identify organisms including interpretation and report | 38 | $6,231 | $120 |
| Pathology examination of tissue using a microscope, intermediate complexity | 130 | $5,755 | $31 |
| Biopsy of related skin growth, first growth | 22 | $2,175 | $91 |
| Short return visit (20+ min) | 18 | $1,217 | $61 |
| Special stained specimen slides to examine tissue, initial procedure | 29 | $1,164 | $29 |
| Special stained specimen slides to examine tissue, each additional procedure | 17 | $1,134 | $24 |
| Special stained specimen slides to identify organisms including interpretation and report | 11 | $265 | $22 |
2022: 11 services
| Pathology examination of tissue using a microscope, intermediate complexity | 4,805 | $542,787 | $71 |
| Special stained specimen slides to examine tissue, initial procedure | 825 | $91,787 | $105 |
| Pathology examination of tissue using a microscope, moderately low complexity | 689 | $31,438 | $43 |
| Special stained specimen slides to examine tissue, each additional procedure | 186 | $27,168 | $93 |
| Special stained specimen slides to identify organisms including interpretation and report | 121 | $17,687 | $118 |
| Biopsy of related skin growth, first growth | 40 | $4,504 | $96 |
| Short return visit (20+ min) | 45 | $3,674 | $71 |
| New patient visit (30+ min) | 23 | $2,051 | $89 |
| Biopsy of related skin growth, each additional growth | 23 | $2,028 | $52 |
| Destruction of precancer skin growth, 1 growth | 26 | $1,495 | $47 |
| Destruction of precancer skin growth, 2-14 growths | 15 | $443 | $7 |
2021: 11 services
| Pathology examination of tissue using a microscope, intermediate complexity | 2,668 | $270,879 | $61 |
| Special stained specimen slides to examine tissue, initial procedure | 377 | $43,400 | $90 |
| Special stained specimen slides to examine tissue, each additional procedure | 116 | $20,363 | $70 |
| Special stained specimen slides to identify organisms including interpretation and report | 156 | $18,696 | $72 |
| Pathology examination of tissue using a microscope, moderately low complexity | 370 | $17,676 | $41 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 61 | $5,973 | $92 |
| Short return visit (20+ min) | 35 | $3,051 | $87 |
| Biopsy of related skin growth, first growth | 19 | $2,000 | $105 |
| Destruction of precancer skin growth, 1 growth | 23 | $1,263 | $55 |
| New patient visit (30+ min) | 11 | $1,090 | $99 |
| Destruction of precancer skin growth, 2-14 growths | 18 | $477 | $7 |
2020: 6 services
| Pathology examination of tissue using a microscope, intermediate complexity | 289 | $26,546 | $35 |
| Special stained specimen slides to identify organisms including interpretation and report | 48 | $5,552 | $54 |
| Special stained specimen slides to examine tissue, each additional procedure | 22 | $5,358 | $48 |
| Special stained specimen slides to examine tissue, initial procedure | 35 | $4,004 | $55 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 24 | $2,273 | $95 |
| Pathology examination of tissue using a microscope, moderately low complexity | 21 | $1,355 | $21 |
Medicaid work
$1,642 in 2024
Medicaid paid $1,642 for 34 billed services this clinician did in 2024, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 34 | $1,642 |
| 2024 | 34 | 1 | 19 | $1,642 |
| 2023 | 79 | 1 | 23 | $1,185 |
| 2022 | 60 | 1 | 16 | $73 |
| 2021 | 147 | 1 | 26 | $2,385 |
| 2020 | 19 | 1 | 15 | $410 |
See the largest Medicaid services in earlier years
2023
| TISSUE EXAM BY PATHOLOGIST | 79 | $1,185 |
2022
| TISSUE EXAM BY PATHOLOGIST | 60 | $73 |
2021
| TISSUE EXAM BY PATHOLOGIST | 147 | $2,385 |
2020
| TISSUE EXAM BY PATHOLOGIST | 19 | $410 |
Money from drug and device companies
$24 in 2025
| 2025 | 1 | 1 | None | $24 |
| 2024 | 1 | 1 | None | $28 |
| 2023 | 2 | 3 | None | $58 |
| 2022 | 2 | 4 | None | $64 |
| 2021 | 2 | 2 | None | $49 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Eterna | $24 | 1 payment
|
See the published payment
| Abbott Laboratories | Meals · 2025-06-11 | Eterna | $24 |
See earlier years (2024, 2023, 2022, 2021)
2024: $28
| Tempus AI | Xt Cdx | $28 | 1 payment
|
2023: $58
| Novartis Pharmaceuticals | Cosentyx | $39 | 2 payments
|
| Genzyme | Dupixent | $19 | 1 payment
|
2022: $64
| Novartis Pharmaceuticals | Cosentyx | $46 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $18 | 1 payment
|
2021: $49
| Genzyme | Dupixent | $25 | 1 payment
|
| Sanofi-Aventis U.S. | Dupixent | $24 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1932561925
- Licence
- CA A149661California A149661: Current · expires 2027-06-30
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207ND0900X (207ND0900X); Federal specialty code 207N00000X (207N00000X); Federal specialty code 207ZD0900X (207ZD0900X); Student in a training program (390200000X)
- Mailing address
- Po Box 31309, Los Angeles, CA, 90031
- NPI first listed
- 2016-03-28
- NPI last updated
- 2023-10-14
- NPI record certified
- 2023-10-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2420 Samaritan Dr, San Jose, CA, 95124